Follicular Cholecystitis: Reappraisal of Incidence, Definition, and Clinicopathologic Associations in an Analysis of 2550 Cholecystectomies.


Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 20 5 2020
medline: 22 6 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

Follicular cholecystitis (FC) is a poorly characterized entity. To determine its frequency/clinicopathologic associations. A total of 2550 cholecystectomy specimens were examined. Two hundred three of these were consecutive routine cholecystectomies submitted entirely for microscopic examination to determine the relative frequency of incidental pathologies in gallbladders (GBs). The remainder had representative sampling. Underlying conditions were nonobstructive pathologies (1270 nonspecific cholecystitis), obstructive (62 distal biliary tract tumors, 35 primary sclerosing cholangitis, and 31 autoimmune pancreatitis), and neoplastic (n = 949). FC was defined as 3 distinct lymphoid follicles (LFs)/centimeter. In the GBs totally submitted for microscopic examination, the true frequency of FC was found to be 2.5% (5/203), and in the representatively sampled group, it was 1.9%, with similar frequencies in nonobstructive, obstructive, and neoplastic cases (2.3%, 3.1%, and 1.3%, respectively, Follicular cholecystitis is seen in 2% of cholecystectomies, typically in significantly older patients, suggesting a deranged immune response. A third of the patients reveal biopsy-proven gastritis. FC does not seem to be associated with autoimmunity, lymphoma, or obstructive pathologies.

Identifiants

pubmed: 32423360
doi: 10.1177/1066896920924079
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

826-834

Auteurs

Burcu Saka (B)

218502Istanbul Medipol University, Istanbul, Turkey.

Bahar Memis (B)

1371Emory University, Atlanta, GA, USA.

Ipek Erbarut Seven (IE)

52982Marmara University, Istanbul, Turkey.

Burcin Pehlivanoglu (B)

1371Emory University, Atlanta, GA, USA.

Serdar Balci (S)

1371Emory University, Atlanta, GA, USA.

Pelin Bagci (P)

52982Marmara University, Istanbul, Turkey.

Michelle Reid (M)

1371Emory University, Atlanta, GA, USA.

Nevra Dursun (N)

Istanbul Research and Training Hospital, Istanbul, Turkey.

Oscar Tapia Escalano (OT)

University of La Frontera, Temuco, Chile.

Juan Carlos Roa (JC)

28033Pontificia Universidad Catolica de Chile, Santiago, Chile.

Juan Carlos Araya (JC)

Hospital Dr. Hernan Henriquez Aravena, Temuco, Chile.

So Yeon Kong (SY)

1371Emory University, Atlanta, GA, USA.

Olca Basturk (O)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jill Koshiol (J)

National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

N Volkan Adsay (NV)

52979Koc University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH